 |
Asklepios BioPharmaceutical
Last updated: January 20, 2024
Sheila Mikhail, CEO
Country: USA | Funding: $241.8M (+)
Website: https://www.askbio.com
Askbio develops meds for range of genetic diseases targeting central nervous system, muscle, respiratory, and heart tissues.
Website: https://www.askbio.com
Askbio develops meds for range of genetic diseases targeting central nervous system, muscle, respiratory, and heart tissues.
